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ABSTRACT
Numerous algorithms have been developed to
analyze ChIP-Seq data. However, the complexity of
analyzing diverse patterns of ChIP-Seq signals,
especially for epigenetic marks, still calls for the de-
velopment of new algorithms and objective com-
parisons of existing methods. We developed
Qeseq, an algorithm to detect regions of increased
ChIP read density relative to background. Qeseq
employs critical novel elements, such as iterative
recalibration and neighbor joining of reads to
identify enriched regions of any length. To object-
ively assess its performance relative to other 14
ChIP-Seq peak finders, we designed a novel
protocol based on Validation Discriminant Analysis
(VDA) to optimally select validation sites and
generated two validation datasets, which are the
most comprehensive to date for algorithmic bench-
marking of key epigenetic marks. In addition, we
systematically explored a total of 315 diverse par-
ameter configurations from these algorithms and
found that typically optimal parameters in one
dataset do not generalize to other datasets.
Nevertheless, default parameters show the most
stable performance, suggesting that they should
be used. This study also provides a reproducible
and generalizable methodology for unbiased com-
parative analysis of high-throughput sequencing
tools that can facilitate future algorithmic
development.
INTRODUCTION
ChIP-Seq is a massively parallel sequencing technique that
has now become the leading tool for studying the dynamic
interplay between transcriptome and epigenome (1).
It enables proﬁling of the genomic locations of immuno-
precipitated DNA fragments bound by transcription
factors, epigenetic marks or other proteins at an unprece-
dented resolution. In a ChIP-Seq experiment, the pro-
tein of interest is initially cross-linked to DNA.
The cross-linked chromatin is then fragmented (e.g. by
sonication or micrococcal nuclease, MNase, digestion)
and enriched by immunoprecipitation using speciﬁc
antibodies. Cross-links are reversed and the enriched
DNA fragments are then ampliﬁed and sequenced using
massively parallel sequencing technologies. The resulting
sequence reads are then mapped to the corresponding
genome sequence for further analysis. To estimate
baseline enrichment, genomic DNA is sequenced without
antibody enrichment (total input). In parallel, non-speciﬁc
binding can be estimated using control antibodies, such
as IgG.
There are several technical aspects of a ChIP-Seq
experiment that can impact the quality of the obtained
data, including but not limited to antibody speciﬁcity,
cell type, selection of negative control, chromatin
fragmentation techniques and sequencing protocol
(e.g. library construction, length of the reads, single or
paired-end experimental protocol and sequencing depth).
Moreover, the identity of the protein or histone mark of
interest can affect the spatial distribution of protein–DNA
interactions. For example, histone marks span broad
genomic regions, from one nucleosome ( 150bp) to
large chromosomal domains, with no evident association
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typically bind to well-deﬁned sequence-speciﬁc regions in
the genome.
As ChIP-Seq protocols and the sequencing technology
have matured over the years, numerous genome-wide
datasets have been generated and the quality of these
datasets has signiﬁcantly improved with deeper coverage.
These advances have been accompanied by a similarly
rapid development of computational tools to analyze
these datasets. In particular, algorithmic performance has
improved from low to high sensitivity (3) by using better
combinations of signal processing strategies, such as cor-
rectionofsequencingbiases,calibrationofsignalfromeach
experimental lane, ﬁltering of PCR artifacts or strand
imbalances and ﬁne-tuning of the parameters of analysis.
Despite the apparent abundance of computational
tools, the need for a simple, parameter-free, yet robust
pipeline warrants development of versatile approaches
that are capable of locating binding events with high sen-
sitivity and speciﬁcity in diverse datasets. These
approaches are required to detect events in multiple
datasets that may have varying length scales, intensities
and gaps from other events. The prediction and localiza-
tion of enriched events in ChIP-Seq data are still not
straightforward computational tasks due to the already
mentioned biological and experimental variations and
other poorly characterized factors (e.g. chromatin com-
paction, proximity of adjacent binding sites). Moreover,
each of the available peak detectors addresses only
a certain set of these aspects, affecting the number and
characteristics of reported events. For example, some of
the ChIP-Seq algorithms are ﬁne-tuned to work with
speciﬁc proteins while others are better suited to analyze
epigenetic marks and require a number of parameters to
be explored by the user (4,5).
The development of ChIP-Seq algorithms has equally
been hindered by limitations in objective benchmarking
standards, resulting in limited efforts to compare their
performances (3). An important aspect in comparative
benchmarking of ChIP-Seq event detectors is to have
sizeable validation sets that are not selected from the pre-
dictions of one single algorithm and are obtained by
independent quantitative PCR (qPCR) experiments (the
gold standard in the ﬁeld). Choosing a set of validation
sites for a comparative study requires a careful design and
therefore we developed a ChIP-Seq speciﬁc protocol based
on our general Validation Discriminant Analysis (VDA)
approach (6). This allowed us to perform an objective
comparison between 15 ChIP-Seq algorithms using
histone modiﬁcation datasets.
In this study, we introduce Qeseq, a novel non-
parametric ChIP-Seq event-ﬁnding algorithm, and system-
atically compare its performance with 14 other programs
in histone modiﬁcation datasets. Using an approach
that integrates selection of validation sites and ranking
of algorithmic performance in an unbiased fashion, we
show that Qeseq is a robust computational tool for
analyzing epigenetic datasets. We also demonstrate
through an extensive parameter optimization effort that
default parameters typically are good choices as they
stand out in terms of their stability in algorithmic
performance.
MATERIAL AND METHODS
Publicly available ChIP-Seq datasets with
qPCR validations
In the present study, we used publicly available his-
tone modiﬁcation ChIP-Seq datasets for lysine 4 tri-
methylation of histone H3 in mouse embryonic stem
(ES) cells (ES.H3K4me3) (7), lysine 27 tri-methylation of
histone H3 in mouse ES cells (ES.H3K27me3) (7)
and in mouse muscle cells (MYO.H3K27me3.GM
and MYO.H3K27me3.MT), and lysine 36 tri-methylation
of histone H3 in mouse muscle cells
(MYO.H3K36me3.GM) (8). qPCR validations were avail-
able for each of the above ChIP-Seq datasets. Additional
information on the datasets and their qPCR validations is
shown in Tables 1 and 2, respectively.
VDA selected qPCR-validated datasets
To rank performances of available ChIP-Seq algo-
rithms, we designed two novel validation datasets
(H3K27me3.GM.VDA and H3K36me3.GM.VDA) using
the VDA approach (Supplementary Notes C and Results
section). qPCR validation sites were considered to be
positive or negative according to empirical ChIP-qPCR
comparing several wild type and knock-out cell lines (9).
These tests, showed that under the ChIP conditions used
(buffers, washes etc), with three biological replicates, a
minimum cutoff for a positive site of 0.05% enrichment
over total input eliminated  98% of false positive events
(P. Asp and B. Dynlacht, unpublished results). This value
is the equivalent of using 5ng of total chromatin as the
qPCR template. Loci where the enrichment of the IgG
control ChIP over total input control was found
>0.05% in two independent ChIP experiments were
removed from the study due to high non-speciﬁc back-
ground. ChIP-qPCR analysis of the VDA selected sites
using the criteria described above generated 197 validated
sites for the MYO.H3K27me3.GM.VDA dataset and 94
validated sites in the MYO.H3K36me3.GM.VDA; 291
validation sites in total (Table 2).
Algorithms. We considered Qeseq and 14 other state-
of-the-art ChIP-Seq tools. We initially tested Qeseq and
10 other algorithms: CCAT (10), ChIPDiff (11),
ERANGE (12), FindPeaks(13), FSeq (14), MACS (15),
PeakSeq (16), QuEST (17), SICER (18) and SISSRs (19).
Table 1. Characterization of the histone modiﬁcation ChIP-Seq
datasets in terms of the number of ChIP and control reads
Histone modiﬁcation ChIP reads Control
reads
ES.H3K27me3 6537926 715231
ES.H3K4me3 8850116 715231
MYO.H3K27me3.GM 29694722 32866230
MYO.H3K27me3.MT 28538546 27406448
MYO.H3K36me3.GM 25322796 32866230
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parative study that were not available when we designed
the validation experiments: RSEG (20), Swembl (21),
TPIC (22) and W-ChIPeaks (23) (Supplementary Table
S1a, b and Supplementary Notes A).
Evaluation of algorithmic performance using qPCR
validation experiments. ChIP-Seq datasets were analyzed
with these 15 algorithms using the default or recom-
mended settings. Predicted events were compared to the
sets of validated sites. All algorithms were run using total
input as control, when required. The performance of each
algorithm was assessed using the area under the receiver
operating characteristic curve (AUCROC) measure, which
for binary predictors (whether DNA binding occurs or
not) is reduced to the balanced accuracy [Equation (3) in
Results section]. To account for the loss of resolution
due to the increased presence of non-mononucleosomal
fragments in the qPCR validation experiments
(Supplementary Notes B and Supplementary Tables
5–6), we added ﬂanking regions to the boundaries of
qPCR-validated sites: 150bp for histone marks according
to the reported average fragment size. A predicted event
was considered a True Positive if it was validated by
qPCR as a positive site, or a False Positive if it was not
validated by qPCR. qPCR validated positive sites were
considered False Negatives if there was no predicted
event; similarly, True Negatives were qPCR validated
negative sites with no predicted event.
RESULTS
Qeseq
Algorithm design. The Qeseq algorithm analyzes aligned
sequence reads from ChIP-Seq data and identiﬁes regions
that show a signiﬁcant enrichment of ChIP signal relative
to the control. Two design choices guided our algorithmic
development: (a) a parameter-free easy-to-use model
combined with (b) high speciﬁcity and improved sensitiv-
ity when measuring algorithmic performance. Reﬂecting
these goals, the algorithm consists of three main
modules: relative enrichment estimation, cluster detection
and ﬁltering of artifacts (Supplementary Figure S1). Qeseq
iteratively cycles through its ﬁrst two modules by
removing detected clusters and reevaluating enrichment
and cluster detection on the remaining signal until no
new events are detected. The third module is used once
to prune artifacts from the results. The average length of
DNA fragments is the only parameter required from the
user, which is determined during ChIP-Seq library prep-
aration and is veriﬁed experimentally as part of most
protocols.
Relative enrichment estimation. This module estimates the
local enrichment of ChIP signal relative to the control
from the raw data (Supplementary Figures S2–S5). The
underlying assumption is that the density of sequencing
reads can be used to determine this enrichment. Qeseq
generates smooth proﬁles for the ChIP sample and
control signal separately on each chromosome using
kernel density estimation (KDE) with ﬁxed bandwidth
(24). We implemented the Gaussian KDE (GKDE) in
Qeseq (Supplementary Figures S2A, S3A, S4 and S5),
although other choices of kernel yield very similar
results (Supplementary Figures S2B, C, D, 3B, C and
D). In particular, we deﬁne the genomic position of a
sequenced read as its start site, and then for a genomic
position x, the experimental density (D) is deﬁned as
follows:
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p
is the kernel bandwidth in base pairs, n is the
total number of reads within the chromosome, and each xj
is the genomic position of a sequenced read within 3h from
x. The densities (D) are computed separately for the ChIP
and the control lanes, such that both densities are
estimated at the genomic positions of reads from the
ChIP lane. For the ChIP signal xj represents the
genomic positions of ChIP reads, and for the control
signal xj represents the genomic positions of control
reads. Because the ChIP and control densities are
evaluated within 3h of the position x of the ChIP reads,
the control lane might not have reads in this genomic
region. We accounted for this bias by adding a
pseudo-count of 1=nh
ﬃﬃﬃ
 
p
to the control density. We
deﬁned the enrichment of the ChIP signal with respect
to the control as the ChIP to control log-ratio (ChIR) of
the two densities. Qeseq computes the ChIR at the
genomic positions x of each read in the ChIP lane as
follows:
ChIRðxÞ¼log2
DChIPðxÞ
DControlðxÞ
k
  
ð2Þ
where DChIPðxÞ and DControlðxÞ are the ChIP and control
densities, respectively, and k is a calibration coefﬁcient
deﬁned as k ¼
P
DControl=
P
DChIP (Supplementary
Figures S4 and S5).
Event detection. At the genomic position of each ChIP
read, we applied the two-sample Crame ´ r-von Mises test
(25,26) to two vectors of the same length representing the
empirical and theoretical ChIR distributions to assess sig-
niﬁcance at the level of a=0.05. Our theoretical distribu-
tion represents the limit of the null distribution when the
Table 2. Characterization of the qPCR validation sites
Histone
modiﬁcation
Positives Negatives Total Source
ES.H3K27me3 17 14 31 (7)
ES.H3K4me3 19 14 33 (7)
MYO.H3K27me3.GM 70 30 100 (8)
MYO.H3K27me3.MT 65 35 100 (8)
MYO.H3K27me3.GM.VDA 145 52 197 VDA
validated
sites
MYO.H3K36me3.GM.VDA 71 23 94 VDA
validated
sites
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the distribution of ChIRs within 3h of the position x of the
ChIR of interest with the theoretical null distribution with
zero mean and zero variance. We assessed the signiﬁcance
of the deviation of the ChIR from the theoretical null
distribution at all the genomic positions covered in the
ChIP lane (Supplementary Figures S6D and S7D).
A candidate event was then deﬁned as a contiguous
genomic region where all the nucleotides within this
interval are within a distance of 3h from a signiﬁcantly
enriched ChIR. Using this deﬁnition we derived the
boundaries of each candidate event (Supplementary
Figures S6E and S7E).
To test the signiﬁcance of each candidate event we again
used the Crame ´ r-von Mises non-parametric test, but this
time it is not applied at the nucleotide level. Rather, this
second test assesses whether the empirical distribution of
ChIRs within the boundaries of a detected candidate
event, is signiﬁcantly different from the theoretical distri-
bution centered at zero (using the cutoff a=0.01). Only
signiﬁcant candidate events are retained as positive events
(Supplementary Figures S6G and S7G).
We note that the ﬁrst test used to deﬁne candidate
events has a less stringent threshold (a=0.05), which
allowed us to improve sensitivity, especially in noisy
extended regions, where the signiﬁcance of individual
ChIRs could be hindered by suboptimal coverage.
Additionally, we note that the Crame ´ r-von Mises test
can detect differences in distributions with higher statis-
tical power than the commonly used two-sample
Kolmogorov-Smirnov test (25).
Recalibration. The expected ChIR value of event-free
regions should be zero. However, the presence of real
binding events generates a heavier right tail in the distri-
bution of the ChIR. We therefore recalibrated the coefﬁ-
cient k [Equation (2)] so that, after masking genomic
regions with candidate events, the ChIR distribution for
each chromosome was centered at zero (Supplementary
Figures S8 and S9). We iteratively repeated calibration,
position and candidate event signiﬁcance assessments on
the remaining genomic regions until no new events were
detected.
Filtering of artifacts. In ChIP-Seq signals, experimental
noise and sequencing artifacts can contribute to the detec-
tion of false events. A common assumption is that reliable
candidate events have substantial average enrichment and
are characterized by roughly equal number of reads from
both DNA strands. To ensure that reported events possess
both these qualities, Qeseq removes events that are
enriched in the control lane relative to a signal constructed
by replacing the read density of every candidate event with
a uniform distribution, representing the average read
density across all events. This procedure identiﬁes and
removes all sites associated with PCR ampliﬁcation arti-
facts as well as spurious or non-speciﬁc enrichment
(Supplementary Figure S10). Furthermore, Qeseq
removes events with a ratio >2:1 between the number of
reads mapped to the positive (negative) and to the
negative (positive) DNA strands, when the total number
of reads in the event is large (Supplementary Figure S11).
Such events can be the result of incorrect mapping of
sequences from repeat elements, or non-speciﬁc immuno-
precipitation (27).
Additional characteristics of Qeseq. Qeseq provides both
browser extensible data (BED) and sequence graph data
(SGR) output formats to facilitate visualization in genome
browsers. The default output of Qeseq consists of useful
information for each event including the number of reads
within the event mapped to each strand, the average ChIR
and the event P-value. All peaks that are ﬁltered out are
stored in a separate ‘false positive events’ ﬁle.
Qeseq is implemented in C+ +and it is freely available
at http://sourceforge.net/projects/klugerlab/ﬁles/qeseq/
Performance comparison
Unbiased evaluation of algorithmic performance. Previous
comparative studies measured algorithmic performance by
assessing the number of events that are correctly classiﬁed
in the test dataset based on speciﬁc qPCR validation
datasets (4,5). The most commonly used measure of per-
formance in these studies is the area under the receiver
operating characteristic curve (AUCROC), which for a
binary predictor i corresponds to the balanced accuracy:
AUCROCi ¼
1
2
TPi
P
+
TNi
N
  
ð3Þ
These earlier comparative studies, however, did not take
into account that sampling biases might have occurred in
the selection of validation sites. In fact, an unbiased
estimate is necessary for validation sets generated using
a biased strategy, such as the VDA approach.
We therefore sought to deﬁne an unbiased estimate of
algorithmic performance (Supplementary Notes C) that is
independent of sampling biases. In detail, we derived a
corrected AUCROC formula for an algorithm i that esti-
mates the number of nucleotides in the genome that would
be correctly classiﬁed as present (or absent) in a binding
event:
AUCROCi ¼
1
2
TPi
P
+
TNi
N
  
ð4Þ
These estimates were computed after partitioning the
genome into sets of nucleotides sharing the same ﬁnger-
print, i.e. a binary vector [A1, A2,..., An] where Ai is 1 if
the nucleotide was predicted as part of a binding site by
algorithm i or 0 otherwise (Supplementary Notes C). The
numbers of nucleotides expected to be true positives TPi,
true negatives TNi, positives P and negatives N were
estimated as (6):
TPi ¼ R 
P
k2W
TPi,k
Pk+Nk  
Ck P
j2W
Cj
0
@
1
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k2W
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Ck P
j2W
Cj
0
@
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A
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as a binary vector [A1, A2,..., An] where Ai is 1 if the
nucleotide was predicted as part of a binding site by algo-
rithm i or 0 otherwise; R is the total number of nucleotides
in the genome; W is the subset of the 2
n possible ﬁnger-
prints, which consists of the union of all ﬁngerprints
associated with the nucleotides covered in the validation
experiment; Ck is the number of nucleotides that have
ﬁngerprint k; Pk and Nk are the number of nucleotides
associated with the ﬁngerprint k that were experimentally
validated as positives and negatives respectively; and TPik
and TNik are the number of nucleotides of ﬁngerprint k
that are correctly identiﬁed as true positives and true nega-
tives by a given algorithm. It follows from this deﬁnition
that our unbiased estimate is not signiﬁcantly different
from previous biased estimates when the validation set is
chosen randomly.
Using the corrected TPi, TNi, P and N deﬁned in
Equation (4), we also derived unbiased estimates of
precision, recall, true negative rate and F-measure (28)
(Figure 1 and Supplementary Table S2). We found
that our unbiased AUCROC formula is robust across
datasets. When comparing algorithmic performance
lower variance is achieved (Figure 2).
Performance analysis based on existing qPCR validations
using unbiased AUCROC measure. We initially assessed
the performance of each algorithm using publicly avail-
able qPCR validation datasets (Table 2). Our unbiased
AUCROC measure [Equation (4)] indicated differences
between algorithms, suggesting that on average the most
recent algorithms had improved performance (Figure 3A
and Tables 3 and 4). Using the existing histone qPCR
validation datasets, ChIPDiff, FindPeaks FSeq, Qeseq,
RSEG, SWEMBL and TPIC have AUCROCs>0.8
in the majority of cases (Figure 3A). On average, in the
four existing datasets the top performing algorithms
had nearly identical AUCROCs: RSEG (average
AUCROC=0.87), Qeseq and FindPeaks (both with
average AUCROC=0.85).
VDA-based design of novel validation datasets. Exper-
imentally validated histone modiﬁcation datasets are
scarce, and most algorithms have been trained and
tested on speciﬁc and small datasets (Supplementary
Notes C). In order to overcome this limitation, we
designed two novel extensive histone modiﬁcation qPCR
datasets.
For a fair comparison between algorithms we sought
to select validation sites by using our VDA approach
(Supplementary Notes C.I), such that the resulting valid-
ation dataset consists of a subset of sites with higher dis-
criminative power than a random subset. Speciﬁcally,
VDA maximizes the minimum number of discordant
predictions between any pair of algorithms (i.e. we want
to choose validation sites such that the minimal discrep-
ancy between any pair of algorithms is maximized).
This procedure enables a more reliable ranking of
Figure 1. Sensitivity and speciﬁcity in qPCR validated histone modiﬁcation datasets. Algorithms are in order of publication. A LOESS estimator has
been added to facilitate visualization. (A) Speciﬁcity statistics of 15 ChIP-Seq algorithms remain almost invariant over time in the range of 0.9–1 in
all four histone modiﬁcation datasets. The minor decrease in speciﬁcity in the newer algorithms is due to less restrictive detection procedures that
allow a signiﬁcant improvement in sensitivity (cf. panel B). (B) Sensitivity statistics of 15 ChIP-Seq algorithms shows an increasing trend over time in
all four datasets.
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the list of all available sites (6).
To select validation sites we initially implemented
the genome segmentation protocol (Supplementary
Notes C.II) based on the predictions obtained
for MYO.H3K27me3.GM with CCAT, ChIPDiff,
ERANGE, FindPeaks, FSeq, MACS, PeakSeq, Qeseq,
QuEST and SISSRs. Myoblast H3K27me3 ChIP-qPCRs
were performed for 115 sites and 99 of these sites were
successfully characterized as H3K27me3 positives or nega-
tives (see ‘Materials and Methods’ section), resulting in 88
positives and 11 negatives. In addition, to further discrim-
inate between the top performing algorithms we designed
a second set of validation sites selected by applying
the ChIP-Seq VDA protocol to predictions from
CCAT, FSeq, MACS, PeakSeq and Qeseq in
MYO.H3K27me3.GM data. This increased the size of
the MYO.H3K27me3.GM.VDA validation set with an
additional 98 sites, which, together with the ﬁrst set,
comprised 197 sites. For these additional 98 sites, we im-
plemented the clean-sites protocol (Supplementary Notes
C.III) to deﬁne candidate sites that improve robustness to
the loss of resolution introduced by conventional qPCR.
To avoid possible bias from using only one histone
mark for testing, we applied the clean-sites protocol
(Supplementary Notes C.III) to the predictions obtained
for another mark, MYO.H3K36me3.GM using CCAT,
FSeq, MACS, PeakSeq and Qeseq. 94 sites (out of 114)
were successfully validated by ChIP-qPCR.
Comparison of algorithmic performance using VDA
datasets. In the H3K27me3.GM.VDA dataset, RSEG
(AUCROC=0.86), FindPeaks (AUCROC=0.84) and
Qeseq (AUCROC=0.84), showed the highest
AUCROCs (Figure 3B and Tables 3 and 4), largely out-
performing all other algorithms. Performances were lower
in the H3K36me3.GM.VDA dataset where the leading
algorithms were Qeseq (AUCROC=0.67) and ChIPDiff
(AUCROC=0.67) (Figure 3B and Tables 3 and 4).
On average, in these two novel validation datasets,
Qeseq (average AUCROC=0.75) and CCAT (average
AUCROC=0.72) had the best performance along with
two HMM-based algorithms, ChIPDiff (average
AUCROC=0.75) and RSEG (average AUCROC
=0.74).
Exploration of the parameter space of ChIP-Seq
algorithms
Design of parameter space exploration. Most algorithms
have a number of parameters that can be set by the user
(Table 5). For any algorithm, exploring the parameter
space to improve performance is time-consuming and
prone to over-ﬁtting (29). Moreover, it is difﬁcult to
predict how results may vary as parameter values are
changed. In addition to our analysis on default settings,
conducted under the assumption that developers have ex-
tensively tested their programs to ensure best average per-
formance, we also explored the parameter space of all the
parametric algorithms considered in our study (Table 5).
We sought to obtain an overview of the effects of different
parameters on the performance, stability and monoton-
icity of such changes. For each algorithm, we modiﬁed
one parameter at a time up to two orders of magnitude
in logarithmic scale around the default value, resulting in
effectively comparing 315 models, each applied to six
Figure 2. Correlation between biased and unbiased AUCROC estimators in qPCR validated histone modiﬁcation datasets. (A) Estimation of
performance using independent validation datasets (MYO.H3K27me3.GM and MYO.H3K27.GM.VDA) derived from the same experiment
showed higher reproducibility when using the unbiased AUCROC estimator (black dots). The biased AUCROC statistics (red dots) consistently
produced higher estimates for the MYO.H3K27me3.GM. Proximity of a dot to the grey diagonal line indicates that the AUCROC estimates of a
given algorithm are similar in two independent validation datasets (B) Heatmap of correlations between performance proﬁles of six histone modi-
ﬁcations. Each proﬁle is a 15D vector representing the performance of the 15 ChIP-Seq algorithms. Colors indicate the degree of correlation, where
red is positive correlation, green is negative correlation and white represents no correlation. Strong anti-correlations between performance proﬁles of
different histone marks are observed when we use the biased AUCROC estimator (orange square). In contrast, the use of the unbiased AUCROC
estimator leads on average to higher correlations between the performance proﬁles (blue square).
e70 Nucleic Acids Research, 2012,Vol. 40,No. 9 PAGE 6 OF 16Figure 3. Comparison of unbiased AUCROC performance estimates in existing and novel qPCR validated histone modiﬁcation datasets. Algorithms
are in order of publication. LOESS estimators have been added to facilitate visualization. (A) AUCROC statistics of the 15 ChIP-Seq algorithms
sorted according to their time of publication shows incremental improvements in existing qPCR validated histone modiﬁcation datasets
(MYO.H3K27me3.GM, MYO.H3K27me3.MT, ES.H3K4me3 and ES.H3K27me3). The lines indicate that over time algorithms achieved better
performance. (B) AUCROC statistics of the 15 algorithms sorted according their time of publication shows incremental improvements in novel
qPCR validated histone modiﬁcation datasets (MYO.H3K27me3.GM.VDA and MYO.H3K36me3.GM.VDA). The lines indicate that over time
algorithms achieved better performance.
Table 3. Performance analysis for each algorithm using the default settings in histone modiﬁcation datasets based on unbiased AUCROC
statistic
Datasets/Algorithms CCAT ChIPDiff ERANGE FindPeaks FSeq MACS PeakSeq Qeseq QuEST RSEG SICER SISSRS SWEMBL TPIC W-ChiPeaks
MYO.H3k27me3.GM.VDA 0.8232 0.8331 0.5038 0.8427 0.7638 0.6583 0.6500 0.8378 0.5011 0.8591 0.5000 0.5089 0.8124 0.8025 0.5085
MYO.H3k36me3.GM.VDA 0.6223 0.6696 0.5000 0.4610 0.6140 0.6148 0.5483 0.6722 0.5000 0.6217 0.6212 0.5002 0.6037 0.6200 0.5000
MYO.H3k27me3.GM 0.8002 0.7879 0.5003 0.7987 0.7931 0.5980 0.6229 0.7991 0.5000 0.7991 0.5000 0.5010 0.7998 0.7993 0.5046
MYO.H3k27me3.MT 0.7355 0.7340 0.5000 0.7350 0.7128 0.5394 0.5590 0.7319 0.5000 0.7354 0.5000 0.5002 0.7362 0.7355 0.5015
ES.H3K4me3 0.8413 0.8426 0.8088 0.8738 0.9742 0.9630 0.4951 0.9940 0.6697 0.9972 0.9970 0.5000 0.9032 0.9814 0.8373
ES.H3K27me3 0.5027 0.9172 0.5826 1.0000 0.8366 0.6757 0.7294 0.8703 0.5551 0.9454 0.8853 0.5000 0.8747 0.8607 0.7185
Table 4. Average performance of each algorithm using the default settings in histone modiﬁcation datasets based on unbiased AUCROC statistic
Datasets/Algorithms CCAT ChIPDiff ERANGE FindPeaks FSeq MACS PeakSeq Qeseq QuEST RSEG SICER SISSRS SWEMBL TPIC W-ChiPeaks
AVERAGE
ALL HISTONE
DATASETS
0.7209 0.7974 0.5659 0.7852 0.7824 0.6749 0.6008 0.8175 0.5377 0.8263 0.6672 0.5017 0.7883 0.7999 0.5951
AVERAGE VDA
DATASETS
0.7227 0.7513 0.5019 0.6518 0.6889 0.6366 0.5991 0.7550 0.5006 0.7404 0.5606 0.5046 0.7081 0.7112 0.5042
AVERAGE
EXISTING
DATASETS
0.7199 0.8204 0.5979 0.8519 0.8292 0.6940 0.6016 0.8488 0.5562 0.8693 0.7206 0.5003 0.8285 0.8442 0.6405
PAGE 7 OF 16 Nucleic AcidsResearch, 2012, Vol.40,No. 9 e70Table 5. Summary of parameter space explored for each algorithm
Algorithms Parameters explored
CCAT Bootstrap pass: number of passes in the bootstrapping process
Minimum count: minimum number of read counts at the peak
Minimum score: minimum score of normalized difference
Moving Step: step of window sliding
SlidingWinSize: size of sliding window
ChIPDiff MaxIterationNum: maximum number of iterations
MinRegionDist: minimum distance between two histone modiﬁcation regions
MinFoldChange: threshold for fold change
MinP: threshold for conﬁdence
MaxTrainingSeqNum: maximum number of sequences for training.
ERANGE Autoshift: calculate a ‘best shift’ for each region
Shiftlearn: pick the best shift based on the best shift for strong sites using the parameter
Notrim: turns off region trimming
NoDirectionality: the fraction of + strand reads required to be to the left of the peak
Minimum: minimum number of reads within the region
Ratio: sets the minimum fold enrichment
Shift: shift reads by half the expected fragment length
Space: sets the maximum distance between reads in the region
FindPeaks DistType: type of distribution used
Iteration: Monte-Carlo FDR for estimating background noise
MinCoverage: modiﬁes the distribution to remove contributions below the supplied height
SubPeaks: turns on the subpeaks module, to perform peak separation
Trim: ﬂoat value is used to determine the amount of the shoulder of each peak retained
WindowSize: size of scanning window
FSeq FeatureLength: feature length
Threshold: standard deviations
MACS MFold: regions within MFOLD range of high-conﬁdence enrichment ratio against background to build model
NoLambda: if True, MACS will use ﬁxed background lambda as local lambda for every peak region
NoModel: whether or not to build the shifting model
PValue: P-value cutoff for peak detection
PeakSeq MaxRegExt: largest region for which the extended region is evaluated
PvalThresh: threshold P-value for a peak
Region: amount on each side that regions are extended when extended regions are used
BinSize: bin size for doing linear regression
WPerC: number of windows per chromosome
WSize: window size for scoring
MinFDR: required false discovery rate
MaxCount: maximum number of reads using the same starting nucleotide
NSims: number of simulations per window to estimate FDR
MaxGap: maximum gap allowed between peaks for them to be merged together
Qeseq There are no parameters to change.
QuEST We tried to change two parameters: quick-window scan and calibrate peak shift. The output format changed,
rendering the results of these parameter changes not applicable to our study.
RSEG Bin: an integer to specify the size of bins used in the program
Desert: an integer value so that if the size of a deadzone is larger than this value, the deadzone is
ignored from subsequent analysis
Distribution: emission distribution used in the program to model read counts
Probability: minimum probability value
Iteration: maximum number of iterations for HMM training
SICER WindowSize: size of the windows to scan the genome width
GapSize: allowed gap in base pairs between islands
FDR: false discovery rate controlling signiﬁcance
SISSRS DirReads: number of ‘directional’ reads required within certain number of base pairs on either
side of the inferred binding site
Pvalue: p-value threshold
Window: size of the overlapping/sliding scanning window
SWEMBL Penalty gradient (p)
Penalty gradient (p) after gap of certain size (d)
Fragment extension: extend fragment in the direction of the read up to a certain length
TPIC Width: width of interval used to calculate local rate g (t)
D: parameter used in discretizing g
Min_Region_Length: size of the overlapping/sliding scanning window
W-ChiPeaks Bin size
FDR: false discovery rate
e70 Nucleic Acids Research, 2012,Vol. 40,No. 9 PAGE 8 OF 16epigenetic datasets. This is an unprecedented effort in the
characterization of parameter space of bioinformatics
algorithms for comparative purposes.
Parameter change affects length scale of detected binding
events. As recently reported (30), the characteristics of
binding events reported by different algorithms vary sig-
niﬁcantly. We found that at default settings most algo-
rithms had an invariant distribution of event lengths,
regardless of the dataset (Figure 4 and Supplementary
Table S3a). We hypothesized that for these algorithms
the characteristic distribution of event lengths is
a function of a subset of parameters. We therefore
examined each algorithm and explored how the length
scales varied by changing one parameter at a time.
We analyzed the MYO.H3K27me3.GM dataset and
observed that the parametric variants of each algorithm
typically clustered together (Figure 5). Within the CCAT,
ERANGE and RSEG clusters, however, we noticed that
there were parameters that substantially affected the dis-
tributions of event lengths. As expected, these changes
were associated with parameters that reduce resolution,
thus increasing the length of predicted events. These par-
ameters were for instance ERANGE’s space, RSEG’s
Gauss distribution, and CCAT’s sliding window size
parameters.
Parameter change affects the number of detected binding
events. To explore the stability of parameters, we per-
formed Principal Component Analysis (PCA) on a
315-by-6 matrix of the number of detected events
to effectively visualize similarities and dissimilarities
between all the 315 models. Since we sought to examine
how varying one parameter impacts the number of
detected events, we projected the data onto the two
leading principal components and drew lines connecting
between models derived by changing a single parameter of
a given algorithm (Figure 6A and Supplementary Table
S3b). For a given algorithm, trajectories stem from the
default setting. Each trajectory corresponds to a single
parameter (Supplementary Notes D). As Qeseq has no
parameters to be explored, its PCA representation is a
point corresponding to the default settings.
Stable parameters have very short and almost lin-
ear trajectories. Therefore, we hypothesized that the
difference between algorithms would be larger than
the difference between the parametric variants of the
same algorithm. On the contrary, we found that most par-
ameter trajectories traversed large regions (Figure 6A) and
the number of detected binding events across the
ChIP-Seq datasets varied signiﬁcantly (spanning more
than four orders of magnitude) between algorithms and
between parametric variants of the same algorithm.
Overall, this suggests that the algorithms could not fully
capture the multi-scale characteristic of a given histone
mark.
Parameter change affects algorithmic performances across
datasets. We further investigated the stability of perform-
ance as parameters were tuned. A desirable property of a
parametric model is that the differences in performance
between its parametric variants are proportionately
Figure 4. Distribution of lengths of binding events detected by 15 ChIP-Seq algorithms in histone modiﬁcation datasets. For each algorithm and for
each dataset the distribution of site lengths is displayed as a density heatmap. The empirical probability of an event length is shown in greyscale, with
darker grey indicating higher probability. Algorithms such as MACS and SISSRs exhibit a short range of event lengths. Other algorithms, such as
ChIPDiff and QuEST have a broader spectrum of site lengths. Default settings were used in all algorithms.
PAGE 9 OF 16 Nucleic AcidsResearch, 2012, Vol.40,No. 9 e70related to the differences in the parameter, such that small
deviations from the default setting would result in small
changes in performance.
To compare performances of the 315 models across
six histone modiﬁcation datasets we applied PCA to a
315-by-6 matrix of unbiased AUCROC measures to
display the dissimilarities between these models (Figure
6B). Additionally, we used a PCA biplot (Figure 7),
which simultaneously displays the multidimensional
models and histone modiﬁcation datasets in 2D (31,32).
Figure 5. Comparison of length scale characteristics of binding events detected by 315 parametric models in MYO.H3K27me3.GM.VDA dataset.
For each parametric model the distribution of site lengths is displayed as a density heatmap. The empirical probability of an event length is shown in
greyscale, with darker grey indicating higher probability. The parametric variants of each algorithmic model are grouped together to simplify
visualization. Most parameters in each algorithm do not affect the length distribution of the detected events.
Figure 6. PCA of the number of detected events and AUCROC performances of 315 ChIP-Seq models in six histone modiﬁcation datasets. (A and
B) Data was projected onto its ﬁrst two principal components using standard PCA. Each of the 15 ChIP-Seq algorithms is shown with a distinctive
color. For each algorithm, there are several trajectories each representing the span of the parametric variants obtained by changing a single
parameter. All the trajectories stem from the default setting. (A) PCA was performed on the number of detected binding events. Long trajectories
reﬂect parametric instability as seen for example in, the trajectories of SISSRs, CCAT and ERANGE. (B) PCA was performed on the AUCROC
statistics. Algorithms whose performance is stable to ﬁne-tuning of parameters have short trajectories, for example TPIC and SWEMBL.
e70 Nucleic Acids Research, 2012,Vol. 40,No. 9 PAGE 10 OF 16PCA allowed us to inspect which algorithmic models and
parameter choices are grouped together, and locate a
region in this space with the top performing models
across all datasets. Moreover, with the aid of the biplot
approach we could observe the approximated perform-
ance of each model in each dataset (Supplementary
Notes D.III).
We observed instability in algorithmic behavior, where
small changes in the choice of parameters often resulted in
large deviations in performance, most notably for
ERANGE, and FindPeaks (Figure 6B). For example,
when we modiﬁed the Subpeaks parameter of FindPeaks
in the MYO.H3K27me3.GM.VDA dataset by one order
of magnitude, we observed that the AUCROC changed
from 0.77 to 0.60 (Supplementary Table S4). Changing
ERANGE’s shift parameter by one order of magnitude
in the ES. H3K4me3 dataset induced AUCROC to drop
from 0.80 to 0.50 (Supplementary Table S4). These par-
ameters impact how short events with few reads are clus-
tered together into longer events. As a result, we found
high correlation between the value of these parameters
and the number of false negatives.
We also observed models generated by the parametric
variants of the CCAT algorithm fall into a cluster. The
performance ranking of the CCAT variants is high in the
MYO datasets. Similarly, the variants of the MACS algo-
rithm are highly ranked in the ES cell datasets. These
results suggest that the different underlying design
choices of these two algorithms capture distinct properties
of the signals. Importantly, ﬁve algorithms (Qeseq, TPIC,
RSEG, SWEMBL and FindPeaks) were high performers
across all datasets.
The choice of optimal parameters varied across different
datasets. A natural way to optimize parameters is by
using minimization procedures. However, as described
above we observed that changes of some parameters led
to strong changes in performance. Although ﬁne-tuning
could still be performed by exhaustive or heuristic search
of the parameter space, the critical question is whether a
model obtained by such a procedure is generalizable to
Figure 7. Biplot of the performances of 315 ChIP-Seq models in six histone modiﬁcation datasets. Data was projected on its two principal com-
ponents using standard PCA techniques. In addition, the vectors corresponding to the six histone modiﬁcation datasets were added as arrows. All
parametric models from 15 ChIP-Seq algorithms are represented by dots identiﬁable by their distinctive colors. In addition, a density heatmap was
added to the background and supplied by isoclines at 25% of the total density. The density heatmap was computed using a 2D Gaussian kernel with
bandwidth of 0.05 in the principal component units. Few algorithms (RSEG, SWEMBLE and CCAT) correspond to parametric models that occupy
small well-deﬁned regions of the PCA space. Other algorithms show a continuous spread of performances (Erange, W-ChIPeaks); others, like SISSRs
have multimodal density distributions, as clearly shown by the presence of multiple disconnected circles.
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single dataset requires extensive validation experiments:
desirably, ﬁne-tuning should be done once and its results
conﬁdently used for all other related datasets.
To determine whether ﬁne-tuning is a recommended step
for analysis of a new ChIP-Seq dataset, we examined if we
could identify a best set of parameters for each algorithm
such that the ﬁne-tuned version would consistently achieve
higher performance than the default settings in all
datasets. We investigated this in two ways: (i) we
checked whether ﬁne-tuning of a single parameter could
improve the performance in each epigenetic dataset, and
(ii) we explored whether, for each algorithm, the optimal
parameter choice in one dataset consistently improved
(not necessarily optimized) algorithmic performance in
all the other datasets with respect to the default
parameter.
When we addressed point (i) above, we noticed that for
algorithms for which the default parameters were not the
best across all datasets, the parameter that led to best
improvement in one dataset was not the one that consist-
ently gave the best improvements in all the other datasets
(Table 6). The only exception was ERANGE for which
ﬁne-tuning of the ‘Space’ parameter resulted in optimal
performance across all epigenetics datasets. Importantly,
across all algorithms, we did not ﬁnd a ﬁxed value for a
single parameter that was optimal across all epigenetic
datasets. The best parameter set for each algorithm in
each dataset is displayed in Table 6. As can be seen
from the table, the optimal values vary across the datasets.
When we addressed point (ii) above, we found that
PeakSeq and SWEMBL had new values for some of the
parameters that consistently led to better performance
across all datasets (Table 7). These new settings led to
longer event sites at lower resolution. However, none of
these optimized performances were higher than the per-
formance of CCAT, ChIPDiff, FSeq, Qeseq RSEG,
SICER and TPIC. We note that these algorithms were
originally optimized for analysis of transcription factor
ChIP-Seq signals. PeakSeq was one of the algorithms
most sensitive to parameter changes, and these conclu-
sions are similar to previous results (33). Importantly,
for the majority of the algorithms, parameter optimization
did not improve performance with respect to default
settings across all datasets, suggesting that in most cases
algorithm developers have satisfactorily optimized default
parameters.
DISCUSSION
In this study, we compared the performances of ChIP-Seq
algorithms in terms of their ability to detect binding events
typical of epigenetic marks, their consistency of perform-
ance across different biological experiments and their
sensitivity to parameter changes.
Undoubtedly, ChIP-Seq algorithms’ optimization
and design choices have been dictated by the available
sequencing technologies. Initial applications were
designed to localize the binding of transcription factors
along the genome that correspond to short regions
(<50bp) sparsely distributed along the genome often
occurring at speciﬁc locations such as transcription start
sites (15,19). More recent ChIP-Seq studies (8) leveraged
on improved sequencing techniques and shed light on the
genome-wide organization of chromatin and the relative
topology of different DNA-interacting proteins.
Given the limits of the initial sequencing efforts in terms
of coverage, one might have anticipated that the ﬁrst gen-
eration of algorithms (ERANGE, FindPeaks, QuEST,
SISSRs, MACS, ChIPDiff, FSEQ and PeakSeq) exhibited
considerable speciﬁcity but low sensitivity (Figure 1).
High speciﬁcity was maintained in the second generation
of algorithms (SICER, CCAT, SWEMBL, TPIC,
W-ChIPeaks, RSEG and Qeseq), while sensitivity signiﬁ-
cantly improved in parallel with sequencing techniques
(thus better signal-to-noise ratio).
Although our analysis spans several years of experimen-
tal and computational improvements, one central question
still remains: is it possible to further improve the analysis
of ChIP-Seq signals? In our study the best performing
algorithms employ different signal processing strategies,
yet they have similar and close to optimal performances
both in pre-existing and in our novel large validation
datasets (Figure 3). This limit may be due to the quality
of the current ChIP and sequencing technologies.
However, our study also demonstrates that certain
features of algorithms can still be improved. For
instance, better characterization of the identiﬁed events
in terms of length spectra (Figure 4), which in principle,
could be ﬁne-tuned by the end-users to optimize perform-
ance. Our analyses suggest that the performance of the
most recent algorithms improved incrementally. We
expect further incremental improvements to take place.
These advancements are necessary and important in that
any investigator would prefer to use the best possible al-
gorithm compared to older less reliable methods. In
addition, there are other equally important improvements
such as speed, simplicity (parameter-free solutions), and
usability in all operating systems (PC, MAC and Linux).
We have also shown that ﬁne-tuning often leads to in-
stability (Figures 5 and 6). In addition, we found that the
set of optimal parameters are not unique across datasets,
not even in experiments analyzing the same protein. Thus,
default parameters are generally recommended for all
algorithms. In this regard, we have introduced a key im-
provement in Qeseq by providing a non-parametric algo-
rithm whose average performance is comparable to the
best available models (Figure 7). Qeseq successfully
incorporated in its design elements of a fully automated
algorithm that can estimate experimental parameters at
run-time and we envision that more parameter-free algo-
rithms will be developed in the future.
In this study we presented a qualitative and quantitative
comparison of 15 ChIP-Seq algorithms in epigenetic
datasets. In order to provide objective and systematic
benchmarking, we designed and applied novel approaches
to select robust experimental validation sets and to
estimate algorithmic performance. The comparative
results obtained are reproducible and generalizable to
other high-throughput data. In this study alongside with
our comprehensive evaluation of ChIP-Seq algorithms we
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PAGE 13 OF 16 Nucleic AcidsResearch, 2012, Vol.40,No. 9 e70Table 7. Comparison of default and benchmarked performances in histone modiﬁcation datasets
Dataset Algorithm Default
AUCROC
Max.
AUCROC
param.
H3.K27
GM-VDA
H3.K36
GM-VDA
H3.K27
GM
H3.K27MT ES.H3K4 ES.H3K2
MYO.H3k27me3.GM.VDA CCAT 0.8232 0.8787 0.0000  0.1938  0.0927  0.1539  0.1670  0.2618
MYO.H3k36me3.GM.VDA CCAT 0.6223 0.6849 0.1938 0.0000 0.1011 0.0400 0.0268  0.0679
MYO.H3k27me3.GM CCAT 0.8002 0.8562  0.2023  0.1768 0.0000  0.0371  0.1646  0.2083
MYO.H3k27me3.MT CCAT 0.7355 0.8191  0.1651  0.1397 0.0371 0.0000  0.1274  0.1712
ES.H3K4me3 CCAT 0.8413 0.8413  0.0181  0.2190  0.0411  0.1058 0.0000  0.3386
ES.H3K27me3 CCAT 0.5027 0.6556  0.0405  0.0124 0.1431 0.0599 0.1595 0.0000
MYO.H3k27me3.GM.VDA ChipDiff 0.8331 0.8331 0.0000  0.1635  0.0452  0.0991 0.0095 0.0841
MYO.H3k36me3.GM.VDA ChipDiff 0.6696 0.6696 0.1635 0.0000 0.1184 0.0644 0.1731 0.2476
MYO.H3k27me3.GM ChipDiff 0.7879 0.7879 0.0452  0.1184 0.0000  0.0539 0.0547 0.1293
MYO.H3k27me3.MT ChipDiff 0.7340 0.7340 0.0991  0.0644 0.0539 0.0000 0.1087 0.1832
ES.H3K4me3 ChipDiff 0.8426 0.9720  0.2687  0.4425  0.2038  0.2418 0.0000  0.1001
ES.H3K27me3 ChipDiff 0.9172 0.9172  0.0841  0.2476  0.1293  0.1832  0.0745 0.0000
MYO.H3k27me3.GM.VDA Erange 0.5038 0.5671 0.0000  0.0672  0.0011  0.0587 0.1681  0.0473
MYO.H3k36me3.GM.VDA Erange 0.5000 0.6110  0.1221 0.0000  0.0921  0.0554 0.1158  0.0243
MYO.H3k27me3.GM Erange 0.5003 0.5712  0.0188  0.0715 0.0000  0.0559 0.3057 0.2937
MYO.H3k27me3.MT Erange 0.5000 0.5557  0.0667 0.0554  0.0367 0.0000 0.1712 0.0311
ES.H3K4me3 Erange 0.8088 0.8770  0.3245  0.3772  0.3057  0.3617 0.0000  0.0121
ES.H3K27me3 Erange 0.5826 0.8649  0.3125  0.3652  0.2937  0.3496 0.0120 0.0000
MYO.H3k27me3.GM.VDA Findpeaks 0.8427 0.8469 0.0000  0.3916  0.0482  0.1119 0.0283 0.1531
MYO.H3k36me3.GM.VDA Findpeaks 0.4610 0.7576 0.0141 0.0000 0.0415  0.0475 0.0654 0.2424
MYO.H3k27me3.GM Findpeaks 0.7987 0.7991  0.0274  0.0415 0.0000  0.0889 0.0239 0.2009
MYO.H3k27me3.MT Findpeaks 0.7350 0.8423  0.1053  0.1348  0.0436 0.0000 0.0419 0.1515
ES.H3K4me3 Findpeaks 0.8738 0.8873  0.1204  0.1868  0.0886  0.0451 0.0000 0.1060
ES.H3K27me3 Findpeaks 1.0000 1.0000  0.1573  0.5390  0.2013  0.2650  0.1262 0.0000
MYO.H3k27me3.GM.VDA Fseq 0.7638 0.8421 0.0000  0.2281  0.0613  0.1373 0.1294  0.0148
MYO.H3k36me3.GM.VDA Fseq 0.6140 0.6355  0.0819 0.0000 0.1635 0.1397 0.2359 0.2272
MYO.H3k27me3.GM Fseq 0.7931 0.7998  0.1106  0.1808 0.0000  0.0698 0.1206 0.0833
MYO.H3k27me3.MT Fseq 0.7128 0.7752  0.2216  0.1397 0.0238 0.0000 0.0962 0.0876
ES.H3K4me3 Fseq 0.9742 0.9995  0.2815  0.4974  0.2062  0.2723 0.0000  0.1975
ES.H3K27me3 Fseq 0.8366 0.8831  0.1939  0.2641  0.0833  0.1531 0.0373 0.0000
MYO.H3k27me3.GM.VDA MACS 0.6583 0.6736 0.0000  0.0549  0.1176  0.1570 0.3139 0.1904
MYO.H3k36me3.GM.VDA MACS 0.6148 0.6247  0.1247 0.0000  0.1247  0.0738 0.2774 0.2205
MYO.H3k27me3.GM MACS 0.5980 0.6061  0.0139  0.0147 0.0000  0.0706 0.2222 0.0697
MYO.H3k27me3.MT MACS 0.5394 0.5553  0.0553 0.0693  0.0553 0.0000 0.4136 0.2775
ES.H3K4me3 MACS 0.9630 0.9886  0.3218  0.3726  0.4046  0.4678 0.0000  0.1212
ES.H3K27me3 MACS 0.6757 0.8674  0.2006  0.2514  0.2834  0.3466 0.1212 0.0000
MYO.H3k27me3.GM.VDA PeakSeq 0.6500 0.7064 0.0000  0.1877 0.0224  0.0757  0.2064 0.0436
MYO.H3k36me3.GM.VDA PeakSeq 0.5483 0.5509 0.0989 0.0000 0.1337 0.0164 0.3755 0.1785
MYO.H3k27me3.GM PeakSeq 0.6229 0.7289  0.0224  0.2101 0.0000  0.0982  0.2289 0.0211
MYO.H3k27me3.MT PeakSeq 0.5590 0.6307 0.0757  0.1119 0.0982 0.0000  0.1307 0.1193
ES.H3K4me3 PeakSeq 0.4951 0.9290  0.2784  0.3803  0.2268  0.3507 0.0000  0.1707
ES.H3K27me3 PeakSeq 0.7294 0.7583  0.1077  0.2096  0.0560  0.1800 0.1707 0.0000
MYO.H3k27me3.GM.VDA Qeseq 0.8378 0.8378 0.0000  0.1656  0.0387  0.1059 0.1562 0.0325
MYO.H3k36me3.GM.VDA Qeseq 0.6722 0.6722 0.1656 0.0000 0.1269 0.0597 0.3218 0.1981
MYO.H3k27me3.GM Qeseq 0.7991 0.7991 0.0387  0.1269 0.0000  0.0672 0.1949 0.0712
MYO.H3k27me3.MT Qeseq 0.7319 0.7319 0.1059  0.0597 0.0672 0.0000 0.2621 0.1384
ES.H3K4me3 Qeseq 0.9940 0.9940  0.1562  0.3218  0.1949  0.2621 0.0000  0.1237
ES.H3K27me3 Qeseq 0.8703 0.8703  0.0325  0.1981  0.0712  0.1384 0.1237 0.0000
MYO.H3k27me3.GM.VDA QuEST 0.5011 0.5011 0.0000  0.0011  0.0011  0.0011 0.1685 0.0540
MYO.H3k36me3.GM.VDA QuEST 0.5000 0.5000 0.0011 0.0000 0.0000 0.0000 0.1697 0.0551
MYO.H3k27me3.GM QuEST 0.5000 0.5000 0.0011 0.0000 0.0000 0.0000 0.1696 0.0551
MYO.H3k27me3.MT QuEST 0.5000 0.5000 0.0011 0.0000 0.0000 0.0000 0.1697 0.0551
ES.H3K4me3 QuEST 0.6697 0.6697  0.1685  0.1697  0.1696  0.1697 0.0000  0.1146
ES.H3K27me3 QuEST 0.5551 0.5551  0.0540  0.0551  0.0551  0.0551 0.1146 0.0000
MYO.H3k27me3.GM.VDA RSEG 0.8591 0.8591 0.0000  0.2374  0.0600  0.1237 0.1381 0.0863
MYO.H3k36me3.GM.VDA RSEG 0.6217 0.7516  0.1824 0.0000 0.0089 0.0866 0.0370 0.1093
MYO.H3k27me3.GM RSEG 0.7991 0.7991 0.0600  0.1773 0.0000  0.0637 0.1981 0.1463
MYO.H3k27me3.MT RSEG 0.7354 0.8387  0.2672  0.0927  0.0411 0.0000 0.1273 0.0223
ES.H3K4me3 RSEG 0.9972 0.9972  0.1381  0.3754  0.1981  0.2618 0.0000  0.0518
ES.H3K27me3 RSEG 0.9454 0.9469  0.0878  0.3252  0.1478  0.2115 0.0503  0.0015
MYO.H3k27me3.GM.VDA SICER 0.5000 0.5000 0.0000 0.1212 0.0000 0.0000 0.4970 0.3853
MYO.H3k36me3.GM.VDA SICER 0.6212 0.7038  0.2038 0.0000  0.2038  0.2038 0.1803 0.2739
MYO.H3k27me3.GM SICER 0.5000 0.5000 0.0000 0.1212 0.0000 0.0000 0.4970 0.3853
MYO.H3k27me3.MT SICER 0.5000 0.7355  0.2355  0.1337  0.2355 0.0000 0.2569 0.1500
ES.H3K4me3 SICER 0.9970 0.9970  0.4970  0.3757  0.4970  0.4970 0.0000  0.1117
ES.H3K27me3 SICER 0.8853 0.9777  0.4777  0.2739  0.4777  0.4777  0.0936 0.0000
(continued)
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comparisons.
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